Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data

BACKGROUND: Patients with unresectable and metastasized gastrointestinal stromal tumor (GIST) experienced a remarkable improvement of progression-free survival (PFS) and overall survival (OS) after the introduction of imatinib. Our hypothesis is that the outcomes of treatment with imatinib are even...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi, Mahmoud, IJzerman, Nikki S., Hollander, Dide den, Bleckman, Roos F., Oosten, Astrid W., Desar, Ingrid M. E., Reyners, An K. L., Steeghs, Neeltje, Gelderblom, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191911/
https://www.ncbi.nlm.nih.gov/pubmed/37079223
http://dx.doi.org/10.1007/s11523-023-00960-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191911/
https://www.ncbi.nlm.nih.gov/pubmed/37079223
http://dx.doi.org/10.1007/s11523-023-00960-y

Ejemplares similares